Back to
GEODE CAPITAL MANAGEMENT, LLC
NNNN6 quarters
Position history for
GEODE CAPITAL MANAGEMENT, LLC's holdings in ANBIO BIOTECHNOLOGY
Yes. Geode Capital Management holds 26,736 shares of NNNN (Anbio Biotechnology), worth $366,550, as of its Q2 2026 13F filing. It increased the position by 973 shares (+3.8%) from Q1 2026. Geode Capital Management has held NNNN since Q1 2025, across 6 quarterly 13F filings.
Current Value
$366,550
Current Shares
26,736
Total Value Change
+$239,283
Total Shares Change
+9,676
Quarter-by-Quarter History
Other major holders of NNNN: MARSHALL WACE, LLP, UBS Group AG, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS